United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-419_236437dc-fce9-b140-992c-b7822562eee5
- Product NDC
- 55111-419
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Lamotrigine
- Labeler
- Dr.Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180906
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-419-05) · 55111-419-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-419-30) · 55111-419-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-419-90) · 55111-419-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →